secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2026-06-18T21:07:11+00:00
Accession:  0001493152-26-029384
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity Technologies closes $3.2M public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Offering of 1,040,000 shares at $0.80 each and pre-funded warrants for 2,960,000 shares at $0.793 each.
- Gross proceeds of $3.2M before fees; net proceeds for working capital and general corporate purposes.
- Post-closing common shares outstanding: 6,283,061.
- Placement agent WallachBeth Capital LLC received 7.5% fee plus $120,000 expense reimbursement.
- Company subject to 30-day lock-up on equity issuances and 3-month ban on variable-rate transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226029384/0001493152-26-029384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226029384/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-029384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer